Cerebral is setting a new standard of quality in integrated mental healthcare for over 100 million commercial insurance members by seamlessly providing therapy and psychiatry in a single point of access including delivery of medications. Our diverse, national network of clinicians train and certify in the Resilience Methodology, which has proven superior clinical outcomes, and delivers relief from symptoms, while equipping clients with abilities to successfully cope with challenges in the future. Getting the care you need is simple with Cerebral. Connect with your care team via virtual sessions complemented by direct, asynchronous messaging. If prescribed, medications can be delivered directly to your door.
Learn more at www.cerebral.com.
MindMed is now Definium Therapeutics, a rebrand that reflects our commitment to forging a new era of psychiatry by applying precision to psychedelic medicine. Follow our new page at the link below!
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
We further our mission by:
● Developing psychedelics and marijuana into prescription medicines
● Training therapists and working to establish a network of treatment centers
● Supporting scientific research into spirituality, creativity, and neuroscience
● Educating the public honestly about the risks and benefits of psychedelics and marijuana